Agostino Perrotta

Title: Agostino Perrotta: Innovator in Anticancer Compounds

Introduction

Agostino Perrotta is a notable inventor based in Bloomfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. With a total of 3 patents to his name, Perrotta's work focuses on innovative solutions for combating solid tumors.

Latest Patents

Among his latest patents, Perrotta has developed intermediates useful in the preparation of diaminothiazoles. These novel diaminothiazoles are selective inhibitors of Cdk4, which play a crucial role in cell cycle regulation. The compounds, along with their pharmaceutically acceptable salts and esters, serve as anti-proliferative agents that are particularly effective in treating or controlling solid tumors, including breast, colon, lung, and prostate cancers. Additionally, he has disclosed pharmaceutical compositions containing these compounds, as well as intermediates useful in their preparation.

Career Highlights

Agostino Perrotta is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has been instrumental in advancing cancer treatment options through innovative research and development.

Collaborations

Perrotta has collaborated with esteemed colleagues such as Qingjie Ding and Paul Gillespie. Their combined expertise has contributed to the successful development of groundbreaking pharmaceutical compounds.

Conclusion

Agostino Perrotta's contributions to the field of pharmaceuticals, particularly in the development of diaminothiazoles, highlight his commitment to advancing cancer treatment. His innovative work continues to pave the way for new therapeutic options in oncology.